Published in Neurosurg Rev on February 28, 2014
Phase-dependent modulation as a novel approach for therapeutic brain stimulation. Front Comput Neurosci (2015) 0.79
Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA (2009) 8.40
A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med (2006) 8.12
Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med (2001) 6.07
Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev (1995) 5.23
Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol (2010) 3.56
Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev (1995) 3.32
Patient-specific analysis of the volume of tissue activated during deep brain stimulation. Neuroimage (2006) 2.89
Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg (2000) 2.25
Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg (2002) 2.25
Statistical determination of the optimal subthalamic nucleus stimulation site in patients with Parkinson disease. J Neurosurg (2007) 2.18
The subthalamic nucleus in the context of movement disorders. Brain (2003) 2.10
Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain (2006) 2.07
Comparison of anatomic and neurophysiological methods for subthalamic nucleus targeting. Neurosurgery (2000) 1.84
Lack of agreement between direct magnetic resonance imaging and statistical determination of a subthalamic target: the role of electrophysiological guidance. J Neurosurg (2002) 1.68
Comparison of atlas- and magnetic-resonance-imaging-based stereotactic targeting of the subthalamic nucleus in the surgical treatment of Parkinson's disease. Stereotact Funct Neurosurg (2008) 1.59
Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. J Neurosurg (2002) 1.51
Safety of anterior commissure-posterior commissure-based target calculation of the subthalamic nucleus in functional stereotactic procedures. Stereotact Funct Neurosurg (2007) 1.48
Intraoperative magnetic resonance imaging findings during deep brain stimulation surgery. J Neurosurg (2011) 1.47
Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Mov Disord (2008) 1.37
Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson's disease and tremor. Mov Disord (2006) 1.34
Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging. Neuroimage (2011) 1.33
Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery (2005) 1.32
The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience (1996) 1.28
Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature. Neurosurgery (2005) 1.24
Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data. AJNR Am J Neuroradiol (2004) 1.24
The connections of the primate subthalamic nucleus: indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitry. Brain Res Brain Res Rev (1997) 1.23
Neuropsychiatric effects of subthalamic neurostimulation in Parkinson disease. Nat Rev Neurol (2010) 1.17
Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology (2000) 1.16
Incidence of symptomatic hemorrhage after stereotactic electrode placement. J Neurosurg (2007) 1.13
Thirty days complication rate following surgery performed for deep-brain-stimulation. Mov Disord (2007) 1.03
CT/MR image fusion in the postoperative assessment of electrodes implanted for deep brain stimulation. Stereotact Funct Neurosurg (2009) 1.00
Stimulation site within the MRI-defined STN predicts postoperative motor outcome. Mov Disord (2012) 0.99
Neurophysiological refinement of subthalamic nucleus targeting. Neurosurgery (2002) 0.97
Subthalamic stimulation for Parkinson disease: determination of electrode location necessary for clinical efficacy. Neurosurg Focus (2005) 0.95
Incidence of hemorrhage associated with electrophysiological studies performed using macroelectrodes and microelectrodes in functional neurosurgery. J Neurosurg (2005) 0.95
Direct visualization of the human subthalamic nucleus with 3T MR imaging. AJNR Am J Neuroradiol (2006) 0.94
Lesion therapy for Parkinson's disease and other movement disorders: update and controversies. Mov Disord (2004) 0.94
The pathophysiological basis of sensory disturbances in Parkinson's disease. J Neurol Sci (2009) 0.93
Brain mapping in stereotactic surgery: a brief overview from the probabilistic targeting to the patient-based anatomic mapping. Neuroimage (2007) 0.93
Influence of uncertainties in the material properties of brain tissue on the probabilistic volume of tissue activated. IEEE Trans Biomed Eng (2012) 0.93
Safety and risk of microelectrode recording in surgery for movement disorders. Stereotact Funct Neurosurg (2002) 0.91
Reliability of atlas-derived coordinates in deep brain stimulation. Acta Neurochir (Wien) (2005) 0.87
Magnetic resonance imaging-based morphometry and landmark correlation of basal ganglia nuclei. Acta Neurochir (Wien) (2002) 0.86
One atlas - three anatomies: relationships of the Schaltenbrand and Wahren microscopic data. Acta Neurochir (Wien) (1999) 0.84
Conventional MRI is inadequate to delineate the relationship between the red nucleus and subthalamic nucleus in Parkinson's disease. Stereotact Funct Neurosurg (2006) 0.82
Subthalamic nucleus deep brain stimulation for Parkinson's disease: magnetic resonance imaging targeting using visible anatomical landmarks. Stereotact Funct Neurosurg (2003) 0.81
Subthalamic nucleus location: relationships between stereotactic AC-PC-based diagrams and MRI anatomy-based contours. Stereotact Funct Neurosurg (2009) 0.80
Discrepancies between the MRI- and the electrophysiologically defined subthalamic nucleus. Acta Neurochir (Wien) (2011) 0.80
New electrophysiological mapping combined with MRI in parkinsonian's subthalamic region. Eur J Neurosci (2009) 0.79
Magnetic resonance-based deep brain stimulation technique: a series of 478 consecutive implanted electrodes with no perioperative intracerebral hemorrhage. Neurosurgery (2009) 0.79
Failure of single-unit neuronal activity to differentiate globus pallidus internus and externus in Parkinson disease. J Neurosurg (2002) 0.77
The role of the supramammillary commissure in MR localization of the subthalamic nucleus. Stereotact Funct Neurosurg (2006) 0.76
Quality index for the quantification of the information recorded along standard microelectrode tracks to the subthalamic nucleus in parkinsonian patients. Neurophysiol Clin (2004) 0.75
Audit of neurophysiological recording during movement disorder surgery. Stereotact Funct Neurosurg (1999) 0.75
Relevance of correction for rotational targeting error in functional neurosurgery. Comput Aided Surg (2006) 0.75
CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res (2007) 6.21
Sodium fluorescein-guided resection under the YELLOW 560 nm surgical microscope filter in malignant brain tumor surgery--a feasibility study. Acta Neurochir (Wien) (2013) 3.41
Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res (2008) 2.84
The variability of atlas-based targets in relation to surrounding major fibre tracts in thalamic deep brain stimulation. Acta Neurochir (Wien) (2014) 2.04
Awake craniotomies without any sedation: the awake-awake-awake technique. Acta Neurochir (Wien) (2013) 2.02
Natural course of sleep-disordered breathing after acute myocardial infarction. Eur Respir J (2012) 1.74
CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol (2008) 1.56
Fluorescein sodium-guided resection of cerebral metastases—experience with the first 30 patients. Acta Neurochir (Wien) (2015) 1.55
Direct visualization of regurgitant orifice by CMR reveals differential asymmetry according to etiology of mitral regurgitation. JACC Cardiovasc Imaging (2011) 1.41
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies. Oligonucleotides (2007) 1.40
Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer (2004) 1.19
When should conservative treatment for lumbar disc herniation be ceased and surgery considered? Neurosurg Rev (2002) 1.18
Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol (2003) 1.11
Salvage therapy in patients with glioblastoma: is there any benefit? Cancer (2003) 1.11
The usefulness of the awake-awake-awake technique. Acta Neurochir (Wien) (2014) 1.08
Clinical progression and genetic analysis in hereditary spastic paraplegia with thin corpus callosum in spastic gait gene 11 (SPG11). Arch Neurol (2004) 1.03
Variable phenotypes of bicuspid aortic valve disease: classification by cardiovascular magnetic resonance. Heart (2010) 1.02
A large, erosive intraspinal and paravertebral gout tophus. Case report. J Neurosurg Spine (2005) 0.98
Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro Oncol (2005) 0.97
High-dose-rate (HDR) brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: long-term results and side effects. Int J Radiat Oncol Biol Phys (2003) 0.97
Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation. Proc Natl Acad Sci U S A (2012) 0.96
Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer. Radiother Oncol (2002) 0.95
The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial. Radiother Oncol (2003) 0.93
Preformed titanium cranioplasty after resection of skull base meningiomas - a technical note. J Craniomaxillofac Surg (2013) 0.92
Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy-- a second chance to preserve the breast. Radiology (2002) 0.91
Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitro. PLoS One (2013) 0.91
Indirect MR arthrography of the shoulder: use of abduction and external rotation to detect full- and partial-thickness tears of the supraspinatus tendon. Radiology (2006) 0.91
Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol (2006) 0.89
Deep brain stimulation for essential tremor: targeting the dentato-rubro-thalamic tract? Neuromodulation (2014) 0.89
Function of carbonic anhydrase IX in glioblastoma multiforme. Neuro Oncol (2012) 0.89
Diagnostic and therapeutic value due to suspected diagnosis, long-term complications, and indication for sural nerve biopsy. Clin Neurol Neurosurg (2005) 0.89
Expression of solute carrier 7A4 (SLC7A4) in the plasma membrane is not sufficient to mediate amino acid transport activity. Biochem J (2002) 0.88
A mathematical model of cerebral circulation and oxygen supply. J Math Biol (2005) 0.88
Neuronatin in a subset of glioblastoma multiforme tumor progenitor cells is associated with increased cell proliferation and shorter patient survival. PLoS One (2012) 0.88
Evaluation of pulmonary vein stenosis after pulmonary vein isolation using a novel circular mapping and ablation catheter (PVAC). Circ Arrhythm Electrophysiol (2011) 0.88
Importance of T2*-weighted gradient-echo MRI for diagnosis of cortical vein thrombosis. Eur J Radiol (2005) 0.88
Impact of sleep-disordered breathing on myocardial salvage and infarct size in patients with acute myocardial infarction. Eur Heart J (2013) 0.87
Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results. J Neurooncol (2009) 0.87
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study. BMC Cancer (2009) 0.87
Skull base meningiomas: neurological outcome after microsurgical resection. J Neurooncol (2013) 0.87
Expression of pigment-epithelium-derived factor during kidney development and aging. Cell Tissue Res (2007) 0.86
Assessment and characterisation of common renal masses with CT and MRI. Insights Imaging (2011) 0.86
Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05). J Neurooncol (2011) 0.85
DTI-based deterministic fibre tracking of the medial forebrain bundle. Acta Neurochir (Wien) (2015) 0.85
Sarcopenia in the aging high-fat fed rat: a pilot study for modeling sarcopenic obesity in rodents. Biogerontology (2012) 0.85
Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II study. J Neurooncol (2004) 0.85
ICAM-1 and VCAM-1 expression following aneurysmal subarachnoid hemorrhage and their possible role in the pathophysiology of subsequent ischemic deficits. Cerebrovasc Dis (2006) 0.84
Level of evidence in the literature concerning brain tumor resection. Clin Neurol Neurosurg (2005) 0.84
A mechanism for the rapid development of intracranial aneurysms: a case study. Neurosurgery (2010) 0.84
Fluorescein Sodium-Guided Surgery of Malignant Brain Tumors: History, Current Concepts, and Future Project. Turk Neurosurg (2016) 0.84
The history and present status of deep hypothermia and circulatory arrest in cerebrovascular surgery. Neurosurg Focus (2006) 0.84
Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis? Biogerontology (2014) 0.84
Computerized data analysis of neuromonitoring parameters identifies patients with reduced cerebral compliance as seen on CT. Acta Neurochir Suppl (2012) 0.82
Identification of early complications following liver transplantation using contrast enhanced ultrasound (CEUS). First results. J Gastrointestin Liver Dis (2012) 0.82
Growth pattern analysis of sphenoid wing meningiomas. Acta Neurochir (Wien) (2010) 0.81
Comparison of conventional abdominal CT with MR-enterography in patients with active Crohn's disease and acute abdominal pain. Acad Radiol (2010) 0.81
Effects of spinal cord stimulation on cortical excitability in patients with chronic neuropathic pain: a pilot study. Eur J Pain (2007) 0.80
Ventricular tapping seems to have no influence on S-100B and NSE serum concentrations. Neurosurg Rev (2004) 0.80
Discrepancies between the MRI- and the electrophysiologically defined subthalamic nucleus. Acta Neurochir (Wien) (2011) 0.80
Lack of correlation between Xenon133 and near infrared spectroscopy/indocyanine green rCBF measurements. Neurol Res (2003) 0.80
Predictors of facet joint syndrome after lumbar disc surgery. J Clin Neurosci (2012) 0.80
The impact of sedation on brain mapping: a prospective, interdisciplinary, clinical trial. Neurosurgery (2014) 0.79
A single neurosurgical center's experience of the resolution of cervical radiculopathy after dorsal foraminotomy and ventral discectomy. J Clin Neurosci (2011) 0.79
Recurrent brain metastases from lung cancer: the impact of reoperation. Acta Neurochir (Wien) (2010) 0.79
Doppler ultrasound measurement of blood flow volume in the extracranial internal carotid artery for evaluation of brain perfusion after aneurysmal subarachnoid hemorrhage. Neurol Res (2007) 0.79
Circulatory arrest and deep hypothermia for the treatment of complex intracranial aneurysms--results from a single European center. Acta Neurochir (Wien) (2010) 0.78
CD95/Fas mediates cognitive improvement after traumatic brain injury. Cell Res (2007) 0.78
Surgical resection of brain metastases-impact on neurological outcome. Int J Mol Sci (2013) 0.78
Evaluation of free flap perfusion with dynamic contrast-enhanced magnetic resonance imaging. Plast Reconstr Surg (2010) 0.78
Feasibility of the custom-made titanium cranioplasty CRANIOTOP(®). Surg Neurol Int (2013) 0.78
Pain resolution after lumbar disc surgery is influenced by macrophage tissue infiltration. A prospective consecutive study on 177 patients. J Clin Neurosci (2002) 0.77
Novel application of T1-weighted BLADE sequences with fat suppression compared to TSE in contrast-enhanced T1-weighted imaging of the neck: cutting-edge images? J Magn Reson Imaging (2012) 0.77
The influence of intraoperative microelectrode recordings and clinical testing on the location of final stimulation sites in deep brain stimulation for Parkinson's disease. Acta Neurochir (Wien) (2012) 0.77